Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of -2.04% and +19.06%, respectively, for the quarter ended September 2026. Do the…
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of -14.55% and +10.73%, respectively, for the quarter ended June 2026. Do the…
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of -9.23% and +16.81%, respectively, for the quarter ended March 2026. Do the…
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of -7.80% and +0.70%, respectively, for the quarter ended December 2025. Do the…
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year…
Senseonics Holdings CEO Goodnow sells $101k in shares By Investing.com Senseonics Holdings CEO Goodnow sells $101k in shares…
Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of -30.30% and +1.79%, respectively, for the quarter ended September 2025. Do the…
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of 0.00% and +4.46%, respectively, for the quarter ended June 2025. Do the…
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused…
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.84%, respectively, for the quarter ended March 2025. Do the…
Senseonics Holdings (SENS) Reports Q4 Loss Senseonics (SENS) delivered earnings and revenue surprises of 33.33% and 0%, respectively, for the quarter ended December 2024. Do the…
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia…
Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company…
Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company…
Senseonics (SENS) Deal With Mercy to Drive Eversense CGM Sales Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive…